查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762332

外用藥CDMO市場，規模，佔有率，趨勢，產業分析報告:各製劑，各類服務，各最終用途，各地區，2025年～2034年的市場預測

Topical Drugs CDMO Market Size, Share, Trends, & Industry Analysis Report By Formulation (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), Service, End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 130 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，全球外用藥物CDMO市場規模預計到2034年將達到1,254.2億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

外用藥物CDMO市場是指為直接用於皮膚或黏膜的藥品開發、製劑和生產提供全面服務的專業公司。這些服務涵蓋外用藥物的整個生命週期，從早期研發到大規模商業化生產。本質上，CDMO是製藥和生物製藥公司的關鍵合作夥伴，幫助他們有效率地將各種外用藥物推向市場，並符合嚴格的監管標準。

濕疹、牛皮癬和痤瘡等各種皮膚病在全球範圍內的流行率不斷上升，刺激了對創新外用藥物的需求。這使得製藥公司依賴在配製和生產複雜外用藥物（包括黏膜藥物）方面擁有專業知識的CDMO。此外，受成本效益和靈活生產能力需求的推動，製藥業外包趨勢日益增長，進一步刺激了對外用CDMO服務的需求。

外用藥物CDMO市場報告重點

按劑型劃分，半固體製劑在2024年佔據最大佔有率，這得益於其在皮膚科、疼痛管理和抗感染等各種治療領域的廣泛應用。

按服務劃分，合約製造業在2024年佔據了市場主導地位，因為製藥公司越來越多地將外用藥物的實際製造外包，以利用專業知識、降低營運成本和可擴展的製造能力。

按最終用途劃分，製藥公司在2024年佔據了最大佔有率，這得益於製藥公司持續開發和商業化從非處方藥到處方藥的各種外用藥物組合。

按地區劃分，2024 年亞太地區佔據外用藥物 CDMO 市場的最大佔有率。這主要得益於製造成本效益、不斷擴大的醫療基礎設施以及中國和印度等國家製藥業的蓬勃發展，使其成為全球外用藥物製造外包的理想地點。

市場主要參與者包括路博潤公司（路博潤生命科學）、Cambrex 公司、龍沙集團、康泰倫特公司、Recipharm AB、皮埃爾法伯公司、Piramal Pharma Solutions、PCI Pharma Services、MedPharm Ltd.、Tergus Pharma 和 Contract Pharmaceuticals Limited。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球外用藥CDMO市場洞察

  • 市場概述
  • 外用藥CDMO市場動態
    • 促進因素和機會
      • 皮膚病發生率上升
      • 醫藥外包的成長趨勢
    • 限制與課題
      • 監管的複雜性和嚴格性
  • PESTEL分析
  • 外用藥CDMO市場應用趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球外用藥CDMO市場:各製劑

  • 主要調查結果
  • 簡介
  • 半固態製劑
  • 液體製劑
  • 固態製劑
  • 經皮吸收型產品

第6章 全球外用藥CDMO市場:各類服務

  • 主要調查結果
  • 簡介
  • 契約開發
  • 契約製造

第7章 全球外用藥CDMO市場:各最終用途

  • 主要調查結果
  • 簡介
  • 製藥公司
  • 生物醫藥品企業
  • 其他

第8章 全球外用藥CDMO市場:各地區

  • 主要調查結果
  • 簡介
    • 外用藥CDMO市場分析:各地區，2020年～2034年
  • 北美
    • 北美:各製劑，2020～2034年
    • 北美:各類服務，2020～2034年
    • 北美:各最終用途，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各製劑，2020～2034年
    • 歐洲:各類服務，2020～2034年
    • 歐洲:各最終用途，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各製劑，2020～2034年
    • 亞太地區:各類服務，2020～2034年
    • 亞太地區:各最終用途，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各製劑，2020～2034年
    • 中東·非洲:各類服務，2020～2034年
    • 中東·非洲:各最終用途，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各製劑，2020～2034年
    • 南美:各類服務，2020～2034年
    • 南美:各最終用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Cambrex Corporation
  • Catalent Inc.
  • Contract Pharmaceuticals Limited
  • MedPharm Ltd.
  • PCI Pharma Services
  • Pierre Fabre S.A.
  • Piramal Pharma Solutions
  • Recipharm AB
  • Tergus Pharma
  • The Lubrizol Corporation(Lubrizol Life Science)
Product Code: PM5815

The topical drugs cdmo market global market size is expected to reach USD 125.42 billion by 2034, according to a new study by Polaris Market Research. The report "Topical Drugs CDMO Market Size, Share, Trends, & Industry Analysis Report By Formulation (Semi-solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products), By Service, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The topical drugs CDMO market refers to specialized companies that provide comprehensive services for the development, formulation, and production of pharmaceutical products designed to be applied directly to the skin or mucous membranes. These services span the entire lifecycle of a topical drug, from initial research and development to the large-scale manufacturing of commercial products. Essentially, CDMOs act as crucial partners for pharmaceutical and biopharmaceutical companies, helping them bring a wide array of topical medications to market efficiently and in compliance with strict regulatory standards.

The increasing global prevalence of various skin conditions, such as eczema, psoriasis, and acne, fuels the demand for innovative topical treatments. This, in turn, leads pharmaceutical companies to rely on CDMOs for their specialized expertise in formulating and producing complex topical medications, including mucosal drugs. Additionally, the growing trend of outsourcing within the pharmaceutical industry, driven by cost-efficiency and the need for flexible manufacturing capabilities, further boosts the demand for topical drugs CDMO services.

Topical Drugs CDMO Market Report Highlights

By formulation, the semi-solid formulations segment held the largest share in 2024 due to their widespread use across various therapeutic areas such as dermatology, pain management, and anti-infectives.

Based on service, the contract manufacturing segment dominated the market in 2024, as pharmaceutical companies increasingly outsource the actual production of their topical drugs to leverage specialized expertise, reduce operational costs, and benefit from scalable manufacturing capabilities.

By end use, the pharmaceutical companies segment held the largest share in 2024 as they consistently develop and commercialize a broad portfolio of topical drugs, from over-the-counter to prescription medications.

By region, Asia Pacific held the largest share of the topical drugs CDMO market in 2024. This is primarily attributed to cost-effectiveness in manufacturing, expanding healthcare infrastructure, and growing pharmaceutical industries in countries such as China and India, making it an attractive hub for global outsourcing of topical drug production.

A few key players in the market include The Lubrizol Corporation (Lubrizol Life Science), Cambrex Corporation, Lonza Group AG, Catalent Inc., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, PCI Pharma Services, MedPharm Ltd., Tergus Pharma, and Contract Pharmaceuticals Limited.

Polaris Market Research has segmented the topical drugs CDMO market report based on formulation, service, end use, and region:

By Formulation Outlook (Revenue - USD Billion, 2020-2034)

Semi-solid Formulations

Creams

Ointments

Gel

Others

Liquid Formulations

Solid Formulations

Transdermal Products

By Service Outlook (Revenue - USD Billion, 2020-2034)

Contract Development

Contract Manufacturing

By End Use Outlook (Revenue - USD Billion, 2020-2034)

Pharmaceutical Companies

Biopharmaceutical Companies

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Topical Drugs CDMO Market Insights

  • 4.1. Topical Drugs CDMO Market - Market Snapshot
  • 4.2. Topical Drugs CDMO Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Skin Conditions
      • 4.2.1.2. Growing Trend of Pharmaceutical Outsourcing
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory Complexity and Stringency
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Topical Drugs CDMO Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Topical Drugs CDMO Market, by Formulation

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • 5.3. Semi-solid Formulations
    • 5.3.1. Global Topical Drugs CDMO Market, by Semi-solid Formulations, by Region, 2020-2034 (USD Billion)
  • 5.4. Liquid Formulations
    • 5.4.1. Global Topical Drugs CDMO Market, by Liquid Formulations, by Region, 2020-2034 (USD Billion)
  • 5.5. Solid Formulations
    • 5.5.1. Global Topical Drugs CDMO Market, by Solid Formulations, by Region, 2020-2034 (USD Billion)
  • 5.6. Transdermal Products
    • 5.6.1. Global Topical Drugs CDMO Market, by Transdermal Products, by Region, 2020-2034 (USD Billion)

6. Global Topical Drugs CDMO Market, by Service

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • 6.3. Contract Development
    • 6.3.1. Global Topical Drugs CDMO Market, by Contract Development, by Region, 2020-2034 (USD Billion)
  • 6.4. Contract Manufacturing
    • 6.4.1. Global Topical Drugs CDMO Market, by Contract Manufacturing, by Region, 2020-2034 (USD Billion)

7. Global Topical Drugs CDMO Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • 7.3. Pharmaceutical Companies
    • 7.3.1. Global Topical Drugs CDMO Market, by Pharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 7.4. Biopharmaceutical Companies
    • 7.4.1. Global Topical Drugs CDMO Market, by Biopharmaceutical Companies, by Region, 2020-2034 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Topical Drugs CDMO Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Topical Drugs CDMO Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Topical Drugs CDMO Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Topical Drugs CDMO Market - North America
    • 8.3.1. North America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
    • 8.3.2. North America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
    • 8.3.3. North America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.4. Topical Drugs CDMO Market - U.S.
      • 8.3.4.1. U.S.: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.3.5. Topical Drugs CDMO Market - Canada
      • 8.3.5.1. Canada: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • 8.4. Topical Drugs CDMO Market - Europe
    • 8.4.1. Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.4. Topical Drugs CDMO Market - UK
      • 8.4.4.1. UK: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.5. Topical Drugs CDMO Market - France
      • 8.4.5.1. France: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.6. Topical Drugs CDMO Market - Germany
      • 8.4.6.1. Germany: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.7. Topical Drugs CDMO Market - Italy
      • 8.4.7.1. Italy: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.8. Topical Drugs CDMO Market - Spain
      • 8.4.8.1. Spain: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.9. Topical Drugs CDMO Market - Netherlands
      • 8.4.9.1. Netherlands: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.10. Topical Drugs CDMO Market - Russia
      • 8.4.10.1. Russia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.4.11. Topical Drugs CDMO Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • 8.5. Topical Drugs CDMO Market - Asia Pacific
    • 8.5.1. Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.4. Topical Drugs CDMO Market - China
      • 8.5.4.1. China: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.5. Topical Drugs CDMO Market - India
      • 8.5.5.1. India: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.6. Topical Drugs CDMO Market - Malaysia
      • 8.5.6.1. Malaysia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.7. Topical Drugs CDMO Market - Japan
      • 8.5.7.1. Japan: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.8. Topical Drugs CDMO Market - Indonesia
      • 8.5.8.1. Indonesia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.9. Topical Drugs CDMO Market - South Korea
      • 8.5.9.1. South Korea: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.10. Topical Drugs CDMO Market - Australia
      • 8.5.10.1. Australia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.5.11. Topical Drugs CDMO Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • 8.6. Topical Drugs CDMO Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.4. Topical Drugs CDMO Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.5. Topical Drugs CDMO Market - UAE
      • 8.6.5.1. UAE: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.6. Topical Drugs CDMO Market - Israel
      • 8.6.6.1. Israel: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.7. Topical Drugs CDMO Market - South Africa
      • 8.6.7.1. South Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.6.8. Topical Drugs CDMO Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • 8.7. Topical Drugs CDMO Market - Latin America
    • 8.7.1. Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.4. Topical Drugs CDMO Market - Mexico
      • 8.7.4.1. Mexico: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.5. Topical Drugs CDMO Market - Brazil
      • 8.7.5.1. Brazil: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.6. Topical Drugs CDMO Market - Argentina
      • 8.7.6.1. Argentina: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
    • 8.7.7. Topical Drugs CDMO Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Cambrex Corporation
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Catalent Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Contract Pharmaceuticals Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. MedPharm Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. PCI Pharma Services
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Pierre Fabre S.A.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Piramal Pharma Solutions
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Recipharm AB
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Tergus Pharma
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. The Lubrizol Corporation (Lubrizol Life Science)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 2 Global Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 3 Global Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 4 North America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 5 North America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 6 North America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 U.S.: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 8 U.S.: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 9 U.S.: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 10 Canada: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 11 Canada: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 12 Canada: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 14 Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 15 Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 16 UK: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 17 UK: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 18 UK: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 France: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 20 France: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 21 France: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 22 Germany: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 23 Germany: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 24 Germany: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Italy: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 26 Italy: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 27 Italy: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 28 Spain: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 29 Spain: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 30 Spain: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 34 Russia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 35 Russia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 36 Russia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 China: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 44 China: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 45 China: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 46 India: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 47 India: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 48 India: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 52 Japan: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 53 Japan: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 54 Japan: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 58 South Korea: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 59 South Korea: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 60 South Korea: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Australia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 62 Australia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 63 Australia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 73 UAE: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 74 UAE: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 75 UAE: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 76 Israel: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 77 Israel: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 78 Israel: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 79 South Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 80 South Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 81 South Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 85 Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 86 Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 87 Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 88 Mexico: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 89 Mexico: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 90 Mexico: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 91 Brazil: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 92 Brazil: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 93 Brazil: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 94 Argentina: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 95 Argentina: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 96 Argentina: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Topical Drugs CDMO Market, by Formulation, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Topical Drugs CDMO Market, by Service, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Topical Drugs CDMO Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Topical Drugs CDMO Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Formulation
  • Figure 7. Global Topical Drugs CDMO Market, by Formulation, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Service
  • Figure 9. Global Topical Drugs CDMO Market, by Service, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Topical Drugs CDMO Market, by End Use, 2024 & 2034 (USD Billion)